We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avon Protection Plc | LSE:AVON | London | Ordinary Share | GB0000667013 | ORD #1 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
16.00 | 1.23% | 1,318.00 | 1,310.00 | 1,316.00 | 1,320.00 | 1,290.00 | 1,310.00 | 32,615 | 16:35:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Rubber,plastics Hose & Belts | 243.8M | -16.4M | -0.5286 | -24.86 | 407.65M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/11/2021 10:23 | Condoms would have been a better rubber line... :) | jdh1602 | |
12/11/2021 10:11 | Best off sticking to what you know, cows still have to be milked and demand for that ever increasing. Working with respiratory and helmets a business they know well, working with very high tech armour for infantry soldiers a whole new ball game. That Wendy acquisition as an alternative to the agricultural a mistake, what you might make in margin you lose in cost over-runs, and the battlefield now very different. USA in retreat globally! | bookbroker | |
12/11/2021 10:07 | It's now a couple of hours since I bit the bullet and dumped my entire holding at 1220p for a 7 grand hit. With hindsight it seems like there has been a slow drip of negative news for a while now (started last year when £40+ and drip drip drip ever since). Takeover rumours will inevitably surface but, with credibility all but gone, fair value would appear to be somewhere below £10. I took the option that I could recover funds quicker by investing elsewhere but the best of luck to remaining holders - hopefully there will be an opportunistic bid to soften the hit somewhat. | jurgenklopp | |
12/11/2021 10:07 | Remember reading this article a few months ago. "It could be a sign of Avon's management not being fully aware of the challenges related to recent acquisitions. At the time of the transaction, market commentators were quick to proclaim 3M sold the ballistics business too cheaply. Could this testing failure be the reason?"https://www. | ianhammond | |
12/11/2021 10:01 | Fun facts - Avon was a Buy twice in last 6 months, in both IC and Shares Magazine, and a Buy on Naked Trader's website in September. I track this stuff carefully. Thanks guys!! | jdh1602 | |
12/11/2021 09:48 | IC had Avon's 12-month Fwd PE at 21 in that article. So it might be less now after the share price drop, but depending on what the real 2022 earnings turn out to be, and the prospects for the future. As always, too many variables that are unknown at this point after the RNS bombshell! | jdh1602 | |
12/11/2021 09:30 | The stock is still trading multiple of sales jdh1602. It is still very expensive | dope007 | |
12/11/2021 09:23 | According to IC last week (when share price was 1945), 2022 forecast Sales were $238m. Today's release is saying $40m is under threat. That's 17% of revenue under threat, but not already written off. The share price is now 42% lower, at 1100. Over-reaction? | jdh1602 | |
12/11/2021 09:12 | Oh dear. Trouble at t’mill. Avon Protection plc Body armor strategic review Avon Protection plc ("Avon Protection" or "the Group") today provides an update on its body armor business. Body armor update Following the contract awards for the U.S. Defense Logistics Agency ("DLA") Enhanced Small Arms Protective Inserts ("ESAPI") and U.S. Army Vital Torso Protection ("VTP") ESAPI body armor plates, we have been engaged with our customers to complete the necessary product approval processes. Disappointingly, the VTP ESAPI plates have encountered a failure in First Article Testing which will significantly delay the likely approval timetable for this product. Separately, we have experienced further delays in obtaining final product approvals for the DLA ESAPI body armor plates, with approvals for this product now expected in the second quarter of our financial year ending 30 September 2022 ("FY22"). Strategic review of body armor business In light of these challenges, the Board has initiated a strategic review of our body armor business. Our FY22 revenue guidance included approximately $40 million of body armor revenue. In light of the above, the financial contribution from our body armor business in FY22 and beyond will be significantly reduced, with the ultimate impact, including any associated cost savings, depending on the outcome of the review process. These issues and the strategic review are restricted to the body armor business, with the Group's leading respiratory protection and helmet product portfolios unaffected. Delay to FY21 results announcement Our underlying trading results for FY21 are expected to be in line with the guidance set out in the post close trading update of 13 October 2021. We have delayed the announcement of our FY21 results, initially planned for 23 November 2021, to allow for a review of the carrying value of the assets related to the body armor business and the additional audit work arising from this post balance sheet event. We will confirm a revised announcement date, which we expect to be in early December, as soon as practicable. We will include an update on our strategic review of our body armor business and provide updated guidance for FY22 and beyond alongside our FY21 results announcement. Salty | saltaire111 | |
12/11/2021 09:10 | Jefferies estimates the risk to FY22/23 forecast consensus EBITDA could be up to 10-15%. It's the reputational damage that is currently most concerning to me as a shareholder. | robinnicolson | |
12/11/2021 08:38 | buywell3 16 Aug '21 - 02:34 - 278 of 412 Edit Skid marks on this chart imo free stock charts from uk.advfn.com Wonder if this got read much ? Supply chain disruptions seem to be very much en vogue | buywell3 | |
12/11/2021 08:36 | Money best allocated elsewhere for quite a while. | p1nkfish | |
12/11/2021 08:33 | buywell3 23 Oct '21 - 22:27 - 382 of 409 Edit buywell can't see a chart bottom as yet which is somewhat of a concern imo | buywell3 | |
12/11/2021 08:30 | Based on sales v mkt cap this still has at least another 50% drop in it | dope007 | |
12/11/2021 08:29 | Destruction of shareholder value and huge reputational damage. Repeat orders?? | pdwop | |
12/11/2021 08:27 | This has another couple of days of price falls in it probably. May be better to wait until next week if looking to buy. | cassini | |
12/11/2021 08:26 | And this is the problem with expensive stocks. Disappointment kills the price | dope007 | |
12/11/2021 08:26 | Massive drop in AVON wow Meanwhile people are accumulating 81% been held at June reporting data/date... remarkably more popular than the share price is saying: | solo4yous | |
12/11/2021 08:26 | I go with 1190 to settle in the next few days | jdh1602 | |
12/11/2021 08:25 | im in at £7.50.. | gripfit | |
12/11/2021 08:20 | 850p I thought was likely | newbold120 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions